Meningitis, Meningococcal — A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
Citation(s)
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants